Thanks, Jon, and good afternoon, everyone. I'll provide a more detailed overview of our Q3 2023 financial performance and then turn it back to Jon before we open the call for questions. Unless stated otherwise, all comparisons in variance commentary on a year-over-year basis. Net sales were $96.9 million, compared to $103.3 million. Domestic sales increased modestly compared to the record year ago period, which was offset by lower international sales, which is a more variable market due to global economic uncertainty, customer mix and a smaller sales base. Gross margin for the quarter was 51%, compared to 60% in the prior year. The decrease was primarily due to lower production efficiencies from new card constructions as well as an impact from inflationary pressures on wages and materials. Net income for the quarter increased 74% to $38 million, compared to $21.9 million in the prior year. The increase was driven by prudent operating expense controls as reflected by a reduction of selling, general and administrative expenses as well as changes to the fair value of the warrants, earnout consideration and derivative liabilities. Adjusted EBITDA in Q3 increased 9% to $35.5 million, compared to $32.7 million in the prior year, and our adjusted EBITDA margin increased approximately 500 basis points to 37% compared to 32% in the third quarter of 2022. The increase in adjusted EBITDA was driven by the aforementioned operating expense controls. On Slide 10, you can see our year-to-date performance. Net sales were up 2% to $290.7 million, driven by our strong sales execution and the resilience of our domestic market, partially offset by lower international sales. Our year-to-date gross margin was 54%, compared to 60% in the prior year due to the lower production efficiency and inflationary pressure from labor and materials. Net income for the first nine months was $81.5 million, compared to $109.5 million in the prior year. The lower net income was driven primarily by the non-cash changes to the fair value of the warrant, earnout, and derivative liabilities. Adjusted EBITDA for the first nine months increased 2% to $107.9 million, compared to $105.6 million in the prior year. Adjusted EBITDA margin for the first nine months of 2023 was 37%, which was flat compared to the prior year. On Slide 11, we'll take a closer look at the split between domestic and international sales. You could see that our domestic sales are holding strong despite comping record results from last year and increased modestly to $84.4 million in the third quarter of 2023, compared to the third quarter of 2022. International net sales for the quarter of 2023 were $12.6 million, with the decrease primarily due to the global economic uncertainty. Moving on to the balance sheet. We had cash and cash equivalents of $23.8 million and total debt of $345 million, which includes $215 million of term loan and $130 million of exchangeable notes. This resulted in a total net debt of $321.2 million. As always, we want to provide both our overall debt leverage and our bank agreement secured debt leverage as our bank agreement is calculated with slight differences. At September 30, our overall leverage ratio was 2.31x based on a net debt of $321.2 million and a trailing 12-month adjusted EBITDA of $138.9 million. This compares to 2.83x at September 30, 2022, with the improvement driven by paying down debt and increased TTM adjusted EBITDA. At September 30, 2023, we had a bank agreement secured debt leverage ratio of 1.48x based on a total secured debt of $215 million and trailing 12-month bank adjusted EBITDA of $145.5 million. This compares to 1.9x at September 30, 2022. I want to turn now to the earnings per share. As a reminder, our method under GAAP for calculating basic and diluted EPS allows us to allocate changes and adjustments of mark-to-market instruments among the public company and the operating subsidiaries to better reflect the actual economic impact on the conversion of such instruments on our net income and our per share basis. GAAP EPS for the three months ended September 30, 2023 was $0.39 per basic share and $0.34 per diluted share. This compares to $0.18 per basic and diluted share in the year ago period. The increase was primarily driven by changes to the fair value of the warrants, earnout consideration, and derivative liabilities primarily driven by the change in our stock price. You can read through the footnotes on the slide that take you through the complexities of the allocation of the net income due to the up fee structure and the shares that are included in the basic and diluted calculations. Turning to Slide 14. You can see how we are tracking with GAAP EPS for the year-to-date, which now puts us at $0.86 per basic share and $0.75 per diluted share. This compares to $1.02 and $0.94 per basic and diluted share, respectively, in the year ago period. Again, this was impacted by the same factors I outlined on the previous slide as non-cash adjustments can have either a positive or a negative impact on net income. On Slide 15, we're also providing a non-GAAP adjusted net income and adjusted EPS, which excludes the impact of the non-cash fair value adjustments for the warrants earnout revaluations and stock comp. We believe this provides a clearer picture of the economics of the company's operating results. With that background, our non-GAAP EPS for the third quarter 2023 was $0.27 per basic share and $0.24 per diluted share. This compares to $0.26 per basic share and $0.22 per diluted share in the year ago period. In the Appendix, you will find a reconciliation between the GAAP and the non-GAAP net income used in these calculations. Turning to Slide 16. Adjusted EPS for the nine months ended September 30, 2023, puts us at $0.83 per basic share and $0.72 per diluted share. This compared to $0.86 and $0.74 per basic and diluted share, respectively, in the year ago period. I'll now turn it back to Jon to discuss our guidance and give closing remarks.